Skip to content

Our Mission

Developing antibody therapies to improve the lives of patients facing severe and life-threatening diseases.

Experienced Leadership Team

Ian Chan wearing a business suit

Ian Chan, MBA

CEO, Co-founder

Eugene Chan wearing business attire

Eugene Chan, MD

Co-founder

Miles Suk wearing a business suit

Miles Suk

 Co-CEO, Chairman

Robert Markelewicz, MD

Chief Medical Officer

Experts on Boards

Bob Langer in a business suit

Robert Langer, PhD

David H. Koch Institute Professor, MIT;
Founder of Moderna, BIND,
Momenta, AIR, others

Dr Laurie Glimcher in business attire

Laurie Glimcher, MD

Former President and CEO,
Dana-Farber Cancer Institute

Ron Levy, MD, wearing a business suit

Ron Levy, MD

Professor and Chief,
Division of Oncology,
Stanford School of Medicine

George Tsokos wearing a business suit

George Tsokos, MD

Professor of Medicine,
Beth Israel Deaconess
Medical Center

Shiv Pillai, PhD, in business attire

Shiv Pillai, PhD

Professor of Medicine,
Harvard Medical School and Massachusetts General Hospital

Steven Schnittman, MD and PhD, wearing a business suit

Steven Schnittman, MD, PhD

Infectious Disease Specialist;
Ex-NIH/Chief HIV Division;
Ex-VP BMS

Board of Directors

Ian Chan wearing a business suit

Ian Chan

CEO, Co-Founder

Miles Suk wearing a business suit

Miles Suk

Chairman

Anthony D. Eisenberg

Ian MacDonald

Sooyoung Lee, PhD

Our Collaborators

celltrion
AstraZeneca
Back To Top